# FDA Inspection 985214 - Novo Nordisk A/S - Hax - June 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/c823f67e-cac7-45bc-8d03-b68b45d4ec26
Source feed: FDA_Inspections

> FDA Inspection 985214 for Novo Nordisk A/S - Hax on June 14, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 985214
- Company Name: Novo Nordisk A/S - Hax
- Inspection Date: 2016-06-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1238387 - 2023-06-01](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/5aa5a4a6-4a88-4eac-8460-0a45d4db839b)
- [FDA Inspection 1056878 - 2018-05-08](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/7ddcaee7-5566-4efb-a61a-7f74fca0f66c)
- [FDA Inspection 950758 - 2015-11-06](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/0693c406-8f6d-41e0-b645-cf694b310769)
- [FDA Inspection 883249 - 2014-05-13](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/bfd75daa-f117-43e2-aad5-1d1fa8a60de6)
- [FDA Inspection 834355 - 2013-05-01](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-hax/4cde4602-433f-4310-8b73-872a0213f16a)

Company: https://www.keypedia.com/companies/novo-nordisk-as-hax/180c323f-b821-4092-81ef-67f1058404d1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c